Device Custom Orthodontics

Clarity Aligners

Payments companies reported to CMS as associated with Clarity Aligners. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$2.9Massociated payments (2023-2025)
7,630clinicians with associated payments
2companies reporting

By year

2023 $996K
2024 $950K
2025 $919K

Payments reported as associated with Clarity Aligners, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthodontics and Dentofacial Orthopedics $2.3M
General Practice (Dentist) $383K
Dentist $160K
Pediatric Dentistry $28K
Periodontics $13K
Prosthodontics $3,276

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Clarity Aligners

These are the largest totals companies reported as associated with Clarity Aligners. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Donna Stenberg Stillwater, MN Orthodontics and Dentofacial Orthopedics $691,028.84
Cranford Langley Daphne, AL Orthodontics and Dentofacial Orthopedics $266,276.73
Patrick O'Neil Daphne, AL Orthodontics and Dentofacial Orthopedics $236,949.64
Christian Groth Ann Arbor, MI General Practice (Dentist) $173,203.78
Douglas Palaganas Wantagh, NY Orthodontics and Dentofacial Orthopedics $107,879.71
Courtney Dunn Litchfield Park, AZ Orthodontics and Dentofacial Orthopedics $94,135.20
Lisa Davison Powell, OH Orthodontics and Dentofacial Orthopedics $90,232.91
Adam Schulhof Oradell, NJ Orthodontics and Dentofacial Orthopedics $78,178.64
Mark Causey Cumming, GA Orthodontics and Dentofacial Orthopedics $72,587.76
David Hime Austin, TX Orthodontics and Dentofacial Orthopedics $54,480.91

Prescribed Clarity Aligners?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.